Viewing Study NCT00646503


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2025-12-29 @ 4:14 PM
Study NCT ID: NCT00646503
Status: COMPLETED
Last Update Posted: 2017-06-22
First Post: 2008-03-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module